Charles River Laboratories International, Inc. has new and continuing collaborations with three drug discovery partners funded by the Wellcome Trust. Antabio, an anti-bacterial drug discovery company, Pcovery, a spin-out company focused on anti-fungals, and the British Columbia Cancer Agency, have all extended existing or entered new agreements with Charles River’s Global Discovery Services business.   As part of the agreements, Charles River will provide a comprehensive suite of in vitro and ...